Strides Shasun has informed that the Exchange vide letter dated April 06, 2016 that they refer to the interview with Rajiv Malik, President of Mylan, published by Economic Times on April 5, 2016 (online edition), in which it was mentioned that Arbitration is going on in London. They wish to clarify that, as on date, there is no arbitration proceeding under way between Mylan and Strides. They had intimated to the Stock Exchanges regarding the Notification of Claims received from Mylan, on December 15, 2015. Since then there are no developments that require any further intimation to the Stock Exchanges.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.25 |
| Dr. Reddys Labs. | 1245.50 |
| Cipla | 1438.75 |
| Zydus Lifesciences | 1150.50 |
| Lupin | 2496.05 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: